Resveratrol could inhibit each stage of multistage carcinogenesis, scavenge incipient populations of androgen-dependent prostate cancer cells through androgen receptor antagonism, and scavenge incipient populations of androgen-independent prostate cancer cells by short-circuiting the epidermal growth factor-receptor-dependent autocrine loops in the cancer cells. Here, EGFR is linked to prostate carcinoma.